Sign Up Today and Learn More About Adimab Stock
Invest in or calculate the value of your shares in Adimab or other pre-IPO companies through EquityZen's platform.
Adimab Stock (ADIM)
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
About Adimab Stock
Founded
2007
Headquarters
Lebanon, NH, US
Total Funding
45.3M
Industries
Science and Engineering, Health Care, Other
Adimab Press Mentions
Stay in the know about the latest news on Adimab
Anti-coagulation factor XI antibodies
patents • Sep 27, 2024
Rationally designed, synthetic antibody libraries and uses therefor
patents • Sep 27, 2024
Adimab Announces Substantial Expansion of Research Campus
businesswire • Apr 24, 2024
Rise of Yeast-Based MAb Tech as Adimab Inks Two More Deals
biopharma-reporter • Apr 24, 2024
LinkedUp, TianTi end legal dispute with Adimab over yeast-based antibody platform
endpts • Jan 14, 2024
Adimab Management
Leadership team at Adimab
General Counsel
Philip Chase
Advisor
Colin Greenspon
Join now and verify your accreditation status to gain access to:
- Adimab current valuation
- Adimab stock price
- Available deals in Adimab and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Adimab stock?
Accredited investors can buy pre-IPO stock in companies like Adimab through EquityZen funds. These investments are made available by existing Adimab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Adimab stock?
Shareholders can sell their Adimab stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
